Status:
RECRUITING
A Technique Improves Urinary Continence in Patients Undergoing Laparoscopic Radical Prostatectomy
Lead Sponsor:
Suzhou Municipal Hospital
Conditions:
Posterior Bladder Wall Reconstruction
Anterior Bladder Wall Reconstruction
Eligibility:
MALE
Up to 79 years
Phase:
NA
Brief Summary
Laparoscopic radical prostatectomy (LRP) is the main treatment method for early prostate cancer, and postoperative urinary incontinence is one of the main complications after LRP. Urologists have appl...
Detailed Description
Prostate cancer is a highly prevalent malignant tumor among men, ranking second in male malignant tumors. Radical prostatectomy (RP) is a primary treatment option for localized prostate cancer, with l...
Eligibility Criteria
Inclusion Criteria:
(1) Preoperative needle biopsy confirmed prostate cancer; (2) The clinical stage is T1 and T2
Exclusion Criteria:
(1) Diseases that significantly increase the risk of surgery or anesthesia, such as severe cardiovascular diseases, respiratory diseases, and coagulation disorders. (2) Patients with extensive bone metastasis or metastases to other organs (3) patients with a history of urinary incontinence and transurethral resection of the prostate. (4) Tumor invasion of bladder neck.
Key Trial Info
Start Date :
January 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06754488
Start Date
January 1 2025
End Date
December 30 2026
Last Update
December 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Suzhou Municipal Hospital
Suzhou, Jiangsu, China, 215000